Toxoplasma gondii is an important opportunistic agent especially in immunocompromised hosts and can cause significant morbidity and mortality. Hence, detection and monitoring of anti-Toxoplasma antibodies are of a great interest in HIV-infected patients. A study on the prevalence of toxoplasmosis and associated risk factors was carried out among HIV-infected patients in Jahrom, southern Iran. The prevalence of anti-Toxoplasma IgG antibodies was 21.1% in HIV-infected patients by ELISA. PCR was performed on all of the samples, and 1 of the blood samples was positively detected. Among the HIV patients, anti-Toxoplasma IgG antibodies were significantly higher in age group of 30-39 years old (P=0.05). The seroprevalence of toxoplasmosis in patients with CD4+<100 cells/μl was 33.3% that was significantly higher than the other groups (P=0.042) with or without IgG antibodies. The CD4+ count mean of seropositive patients was lower than that of seronegative patients. The seroprevalence of toxoplasmosis in patients with highly active antiretroviral therapy was significantly less than patients without therapy (P=0.02). In conclusion, this study showed low seroprevalence of latent toxoplasmosis among HIV-infected patients in the region and confirmed the need for intensifying prevention efforts among this high-risk population and also the risk of toxoplasmosis reactivation which could be important among this population.
Citations
Citations to this article as recorded by
The Global Prevalence of and Factors Associated with Parasitic Coinfection in People Living with Viruses: A Systematic Review and Meta-Analysis Yan Ge, Huaman Liu, Ningjun Ren, Abdul Qadeer, Ian Kim B. Tabios, Ian Kendrich C. Fontanilla, Lydia R. Leonardo, Banchob Sripa, Guofeng Cheng Pathogens.2025; 14(6): 534. CrossRef
Association of polymorphism of IL‐17A, IL‐17F, and IL‐6 with Toxoplasma gondii infection susceptibility in HIV/AIDS patients in Shiraz, southern Iran Maryam Nejabat, Mohammadreza Heydari, Mohammad Motamedifar, Zohre Foroozanfar, Saeid Amirizadeh Fard, Ava Hashempour, Nazani Nazari, Esmaeil Rezaei, Zahra Heydari Immunity, Inflammation and Disease.2024;[Epub] CrossRef
RPA-CRISPR/Cas9-based method for the detection of Toxoplasma gondii: A proof of concept Mengchen Wu, Haiyan Wu, Xueqiu Chen, Fei Wu, Guangxu Ma, Aifang Du, Yi Yang Veterinary Parasitology.2024; 327: 110115. CrossRef
Toxoplasma gondii, HBV, and HCV co‐infection and their correlation with CD4 cells among Iranian HIV‐positive patients Ahmadreza Bazmjoo, Mohammad Aref Bagherzadeh, Rahim Raoofi, Ali Taghipour, Samaneh Mazaherifar, Hojatallah Sotoodeh, Zahra Ostadi, Enayat Shadmand, Mirza Ali Mofazzal Jahromi, Amir Abdoli Immunity, Inflammation and Disease.2023;[Epub] CrossRef
Prevalence of Toxoplasma gondii in HIV-Infected Individuals in Iran: A Systematic Review and Meta-Analysis Pegah Shakib, Masoud Behzadifar, Hossein Mahmoudvand, Sara Larki, Hamed Kalani, Masoomeh Zivdari, Omid Mardanshah, Kourosh Cheraghipour Current HIV Research.2023; 21(4): 221. CrossRef
Seroprevalence of Toxoplasma gondii
in people at an increased risk of HIV
infection – a pilot study Małgorzata Smoguła, Marta Pawłowska, Roland Wesołowski, Karolina Szewczyk-Golec, Celestyna Mila-Kierzenkowska Diagnostyka Laboratoryjna.2022; 58(1): 9. CrossRef
Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV+/AIDS Patients in Northern Iran Hasan Rafati-Sajedi, Bijan Majidi-Shad, Reza Jafari-Shakib, Zahra Atrkar-Roshan, Mohammad Reza Mahmoudi, Seyed Mahmood Rezvani Acta Parasitologica.2021; 66(4): 1417. CrossRef
Investigating the risk factors for seroprevalence and the correlation between CD4+ T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon Eugene Enah Fang, Raymond Babila Nyasa, Emmanuel Menang Ndi, Denis Zofou, Tebit Emmanuel Kwenti, Edith Pafoule Lepezeu, Vincent P. K. Titanji, Roland N. Ndip, Mohammed Abdelfatah Mosa Alhoot PLOS ONE.2021; 16(12): e0256947. CrossRef
The first report of the evaluation of the knowledge regarding toxoplasmosis among health professionals in public health centers in Rabat, Morocco Majda Laboudi, Sanaa Ait Hamou, Imane Mansour, Ilham Hilmi, Abderrahim Sadak Tropical Medicine and Health.2020;[Epub] CrossRef
Toxoplasmosis Among HIV Patients and Healthy Volunteers in Port Harcourt, Rivers State, Nigeria Evelyn O Onosakponome, Austin E Abah, Michael Wogu International Journal of Infection.2020;[Epub] CrossRef
Seroprevalence of Toxoplasma gondii in HIV-infected patients admitted to a university hospital Pinar ERGEN, Fatma YILMAZ-KARADAĞ, Özlem AYDIN Journal of Health Sciences and Medicine.2020; 3(4): 372. CrossRef
Sero-molecular evaluation of Toxoplasma gondii infection among HIV-positive patients Ehsan Ahmadpour, Reza Pishkarie-Asl, Adel Spotin, Hossein Samadi Kafil, Hasan Didarlu, Yaghob Azadi, Aleksandra Barac Transactions of The Royal Society of Tropical Medicine and Hygiene.2019; 113(12): 771. CrossRef
Toxoplasma gondii: The Prevalence and Risk Factors in HIV-Infected Patients in Fars Province, Southern Iran Nasir Arefkha, Bahador Sarkari, Masood Afrashteh, Zahra Rezaei, Mona Dehghani Iranian Red Crescent Medical Journal.2018;[Epub] CrossRef
First
Prev
